Published in Pharma Investments, Ventures and Law Weekly, June 4th, 2006
Revenue for the fiscal fourth quarter of 2006 was $13.8 million, up 28% compared to revenue of $10.8 million in the same period of fiscal 2005. Revenue for the fiscal year 2006 reached $43.7 million, up 14% over fiscal year 2005 and up 70% over the last 2 years.
Recent financial and operating highlights include:
1) Strong U.S. growth with a 28% increase in total revenue for the quarter and 134% growth in AB5000 Consoles revenue.
2) Total worldwide revenue for consoles (Impella and AB5000) for the fourth quarter...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.